Literature DB >> 23510311

The association between diagnosed glaucoma and cataract and cognitive performance in very old people: cross-sectional findings from the newcastle 85+ study.

Joanna M Jefferis1, John-Paul Taylor, Joanna Collerton, Carol Jagger, Andrew Kingston, Karen Davies, Tom Kirkwood, Michael P Clarke.   

Abstract

PURPOSE: Common age-related eye diseases including glaucoma, cataract and age-related macular degeneration (AMD) have been proposed to be associated with dementia. Few studies have examined the relationship between cognition and cataract or glaucoma. We explored the association between cognition and cataract and glaucoma diagnoses in community-dwelling 85-year-olds.
METHODS: Cross-sectional analysis of data from the Newcastle 85+ Study. Diagnoses of eye disease were extracted from family practice records. Cognitive performance was assessed by the standardized mini-mental state examination (sMMSE) and the sMMSE-blind (MMblind). Relationships between glaucoma diagnosis or cataract diagnosis and lower cognition were examined using ordinal logistic regression.
RESULTS: Complete data were available for 839 participants. Of these, 36.0% (302/839) had recorded previous cataract surgery, 11.2% (94/839) untreated cataract and 7.9% (66/839) diagnosed glaucoma. Glaucoma diagnosis was associated with lower sMMSE results (odds ratio [OR] 1.76, 95% confidence interval [CI] 1.05-2.95); but not lower MMblind (OR 1.17, 95% CI 0.65-2.12). When compared to no cataract, cataract diagnosis (treated and untreated combined) was associated with higher sMMSE (OR 0.55, 95% CI 0.38-0.79) and MMblind (OR 0.51, 95% CI 0.34-0.76). Previously treated cataract was associated with higher sMMSE (OR 0.72, 95% CI 0.59-0.88) and MMblind (OR 0.68, 95% CI 0.55-0.85). Untreated cataract was not significantly associated with sMMSE (OR 0.65, 95% CI 0.36-1.19) or MMblind (OR 0.73, 95% CI 0.39-1.36).
CONCLUSIONS: This large epidemiological study of 85-year-olds found that lower sMMSE but not MMblind was associated with glaucoma diagnosis, suggesting the association may be driven by poor vision. Cataract diagnosis was associated with higher sMMSE and MMblind. Reasons for this observation are unclear but may relate to enhanced help-seeking behavior in people with diagnosed cataract.

Entities:  

Mesh:

Year:  2013        PMID: 23510311      PMCID: PMC4121672          DOI: 10.3109/09286586.2012.757626

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  45 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  A high response is not essential to prevent selection bias: results from the Leiden 85-plus study.

Authors:  A Bootsma-van der Wiel; E van Exel; A J M de Craen; J Gussekloo; A M Lagaay; D L Knook; R G J Westendorp
Journal:  J Clin Epidemiol       Date:  2002-11       Impact factor: 6.437

3.  Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease.

Authors:  Lee E Goldstein; Julien A Muffat; Robert A Cherny; Robert D Moir; Maria H Ericsson; Xudong Huang; Christine Mavros; Jennifer A Coccia; Kyle Y Faget; Karlotta A Fitch; Colin L Masters; Rudolph E Tanzi; Leo T Chylack; Ashley I Bush
Journal:  Lancet       Date:  2003-04-12       Impact factor: 79.321

4.  Assessing proportionality in the proportional odds model for ordinal logistic regression.

Authors:  R Brant
Journal:  Biometrics       Date:  1990-12       Impact factor: 2.571

5.  Optic nerve damage in Alzheimer's disease.

Authors:  A A Sadun; C J Bassi
Journal:  Ophthalmology       Date:  1990-01       Impact factor: 12.079

6.  Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study.

Authors:  P Mitchell; W Smith; K Attebo; P R Healey
Journal:  Ophthalmology       Date:  1996-10       Impact factor: 12.079

7.  Conditions associated with Alzheimer's disease at death: case-control study.

Authors:  V Chandra; N E Bharucha; B S Schoenberg
Journal:  Neurology       Date:  1986-02       Impact factor: 9.910

8.  Improvement in cognitive impairment after cataract surgery in elderly patients.

Authors:  Hiroki Tamura; Hidetoshi Tsukamoto; Satoshi Mukai; Tomoko Kato; Atsushi Minamoto; Yuko Ohno; Hidetoshi Yamashita; Hiromu K Mishima
Journal:  J Cataract Refract Surg       Date:  2004-03       Impact factor: 3.351

Review 9.  Epidemiology of risk factors for age-related cataract.

Authors:  S K West; C T Valmadrid
Journal:  Surv Ophthalmol       Date:  1995 Jan-Feb       Impact factor: 6.048

10.  The Lens Opacities Case-Control Study. Risk factors for cataract.

Authors:  M C Leske; L T Chylack; S Y Wu
Journal:  Arch Ophthalmol       Date:  1991-02
View more
  11 in total

1.  Correlation between visual acuity and cognitive functions.

Authors:  Sivan M Elyashiv; Esther L Shabtai; Michael Belkin
Journal:  Br J Ophthalmol       Date:  2013-10-29       Impact factor: 4.638

2.  Aging With Vision Loss: A Framework for Assessing the Impact of Visual Impairment on Older Adults.

Authors:  Bonnielin K Swenor; Moon J Lee; Varshini Varadaraj; Heather E Whitson; Pradeep Y Ramulu
Journal:  Gerontologist       Date:  2020-08-14

3.  Cognitive functions and normal tension glaucoma.

Authors:  Akvile Daveckaite; Evelina Grusauskiene; Kestutis Petrikonis; Antanas Vaitkus; Lina Siaudvytyte; Ingrida Januleviciene
Journal:  Indian J Ophthalmol       Date:  2017-10       Impact factor: 1.848

Review 4.  Synaptic Dysfunction in Alzheimer's Disease and Glaucoma: From Common Degenerative Mechanisms Toward Neuroprotection.

Authors:  Chiara Criscuolo; Carlotta Fabiani; Elisa Cerri; Luciano Domenici
Journal:  Front Cell Neurosci       Date:  2017-02-27       Impact factor: 5.505

5.  Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study.

Authors:  Nienke Legdeur; Maryam Badissi; Stephen F Carter; Sophie de Crom; Aleid van de Kreeke; Ralph Vreeswijk; Marijke C Trappenburg; Mardien L Oudega; Huiberdina L Koek; Jos P van Campen; Carolina J P W Keijsers; Chinenye Amadi; Rainer Hinz; Mark F Gordon; Gerald Novak; Jana Podhorna; Erik Serné; Frank Verbraak; Maqsood Yaqub; Arjan Hillebrand; Alessandra Griffa; Neil Pendleton; Sophia E Kramer; Charlotte E Teunissen; Adriaan Lammertsma; Frederik Barkhof; Bart N M van Berckel; Philip Scheltens; Majon Muller; Andrea B Maier; Karl Herholz; Pieter Jelle Visser
Journal:  BMC Geriatr       Date:  2018-11-26       Impact factor: 3.921

6.  Vision impairment and cognitive decline among older adults: a systematic review.

Authors:  Niranjani Nagarajan; Lama Assi; V Varadaraj; Mina Motaghi; Yi Sun; Elizabeth Couser; Joshua R Ehrlich; Heather Whitson; Bonnielin K Swenor
Journal:  BMJ Open       Date:  2022-01-06       Impact factor: 3.006

7.  A Bayesian Approach to Identifying New Risk Factors for Dementia: A Nationwide Population-Based Study.

Authors:  Yen-Hsia Wen; Shihn-Sheng Wu; Chun-Hung Richard Lin; Jui-Hsiu Tsai; Pinchen Yang; Yang-Pei Chang; Kuan-Hua Tseng
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

8.  Longitudinal changes in global and domain specific cognitive function in the very-old: findings from the Newcastle 85+ Study.

Authors:  Blossom C M Stephan; Graciela Muniz-Terrera; Antoneta Granic; Joanna Collerton; Karen Davies; Brian K Saxby; Keith A Wesnes; Thomas B L Kirkwood; Carol Jagger
Journal:  Int J Geriatr Psychiatry       Date:  2017-06-22       Impact factor: 3.485

9.  Association between cognitive performance and self-reported glaucoma in middle-aged and older adults: a cross-sectional analysis of ELSA-Brasil.

Authors:  K S Vidal; C K Suemoto; A B Moreno; B Duncan; M I Schmidt; M Maestri; S M Barreto; P A Lotufo; L Bertola; I M Bensenor; A R Brunoni
Journal:  Braz J Med Biol Res       Date:  2020-10-30       Impact factor: 2.590

10.  Glaucomatous visual fields and neurocognitive function are independently associated with poor lane maintenance during driving simulation.

Authors:  David E Anderson; John P Bader; Emily A Boes; Meghal Gagrani; Lynette M Smith; Jideofor K Ndulue; Sachin Kedar; Vikas Gulati; Deepta A Ghate; Matthew Rizzo
Journal:  BMC Ophthalmol       Date:  2020-10-20       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.